Lilly's Next-Gen Weight-Loss Drug Clears Trial With Near-Bariatric Surgery Results
--------------------------------------------------------------------
Source: Zero Hedge
Published: 2026-05-21 23:40 UTC+10:00
Section: General
Factuality Score: 100
Opinion Category: Neutral
Topics: Business, Health, Law & Courts, Drugs, Crime & Justice
--------------------------------------------------------------------
Snippet:
Eli Lilly reported positive Phase 3 results for its next-generation obesity drug, retatrutide, which delivered weight-loss results on par with those of bariatric surgery.
--------------------------------------------------------------------